NCT05493007

Brief Summary

This study is a double blind, randomized controlled trail. condition/disease: acute low back pain treatment/intervention: motion style acupuncture treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2021

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2022

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

August 5, 2022

Last Update Submit

October 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale(NRS) of Low back pain

    The extent of Low back pain and discomfort will be assessed using NRS. NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their low back pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

    Change from baseline NRS at 4 days

Secondary Outcomes (11)

  • Visual Analogue Scale (VAS) of Low back pain

    visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days)

  • Numeric Rating Scale(NRS) of leg pain

    visit1(day1), visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days), visit6(1 month after discharge), visit7(3 months after discharge)

  • Visual Analogue Scale (VAS) of leg pain

    visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days)

  • Physical examination (Lumbar range of motion)

    visit2(day2), visit3(day3), visit4(day4), day of discharge(up to 14days)

  • Oswestry Disability Index (ODI)

    visit2(day2), day of discharge(up to 14days), visit6(1 month after discharge), visit7(3 months after discharge)

  • +6 more secondary outcomes

Study Arms (2)

Sandbag motion style acupuncture treatment

EXPERIMENTAL

The MSAT group will recieve 3 sessions of MSAT; on second, third, fourth day after hospitalization. A trained doctor of Korean medicine with at least 3 years of clinical experience will conduct the MSAT. The MSAT group will be also treated with other Korean medical treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Procedure: Sandbag motion style acupuncture treatmentProcedure: Korean medical treatment

Korean medical treatment

ACTIVE COMPARATOR

The control group will be received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine

Procedure: Korean medical treatment

Interventions

Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. This treatment involves patients with musculoskeletal pain to move the part of their body actively during acupuncture treatment under physicians' observation.

Sandbag motion style acupuncture treatment

acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine.

Korean medical treatmentSandbag motion style acupuncture treatment

Eligibility Criteria

Age19 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 19-70 years on the date they sign the consent form
  • Patients who needs hospitalization due to acute low back pain that occurred within 7 days after traffic accident
  • Patients with NRS ≥ 5 for low back pain
  • Patients who provide consent to participate in the trial and return the informed consent form

You may not qualify if:

  • Patients with a specific serious disease that may cause spinal pain: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Patients with progressive neurological deficits or with severe neurological symptoms
  • Patients who have had surgery or procedures within the last three weeks
  • The cause of pain is due to soft tissue disease, not the spine: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
  • Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
  • Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
  • If acupuncture is inadequate or unsafe: patients with hemorrhagic, receiving anticoagulants, severe diabetes and cardiovascular disease
  • Patients who are pregnant or planning to become pregnant
  • Patients with a serious mental illness
  • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • Patients who are difficult to complete the research participation agreement
  • Other patients whose participation in the trial is judged by a researcher to be problematic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jaseng Hospital of Korean Medicine

Seoul, Gangnam-Gu, 135-896, South Korea

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • In-Hyuk Ha, PhD

    Jaseng Medical Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

August 5, 2022

First Posted

August 9, 2022

Study Start

July 17, 2021

Primary Completion

September 26, 2022

Study Completion

September 26, 2022

Last Updated

October 10, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations